Abstract
Medico-economic analysis of the cost-effectiveness of Zilver PTX compared to bare Misago RX in primary stenting of femoropopliteal lesions (BATTLE Randomized Trial)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have